📰 Mark Upsdell News
Page 2 - Mark Upsdell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Upsdell. Real-time updates on events, politics, business and more.
September 14, 2023
Press Releases Press Release Rapid Dose Provides Update on Private Placement ...
July 26, 2023
Press Releases Press Release MARK UPSDELL FILES EARLY WARNING REPORT July 26,...
July 24, 2023
Press Releases Press Release Rapid Dose Closes First Tranche of Private Placement Financing ...
July 7, 2023
Rapid Dose Therapeutics Corp. Corporate Update
May 11, 2023
QuickStrip™ Xylitol and Lidocaine to offer consumers needle-free options for dental proceduresBURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation has launched two unique dental QuickStrip™ products...
April 15, 2023
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is announcing changes to its board of directors.Jason Lewis has resigned as a director of the Company. We thank him...
April 15, 2023
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announces that further to the review by the Ontario Securities Commission (“OSC”) of the Company’s continuous disclosure record, and a subsequent request from staff of the OSC in connection therewith, the Company...
February 1, 2023
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year.Now that the Company has completed the filing of its audited financial statements for the fiscal year ended February 28, 2022...
December 13, 2022
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated November 11, 2022, the Company and its auditors are continuing to work diligen...
November 8, 2022
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to work dilige...